Chemclin Diagnostics Co., Ltd.
Shanghai Stock Exchange 688468.SS
Chemclin Diagnostics Co., Ltd. Goodwill for the year ending December 31, 2023: USD 21.66 M
Chemclin Diagnostics Co., Ltd. Goodwill is USD 21.66 M for the year ending December 31, 2023, a -2.80% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
-
Chemclin Diagnostics Co., Ltd. Goodwill for the year ending December 31, 2022 was USD 22.28 M, a -7.92% change year over year.
-
Chemclin Diagnostics Co., Ltd. Goodwill for the year ending December 31, 2021 was USD 24.20 M, a 2.73% change year over year.
-
Chemclin Diagnostics Co., Ltd. Goodwill for the year ending December 31, 2020 was USD 23.56 M, a 6.69% change year over year.
-
Chemclin Diagnostics Co., Ltd. Goodwill for the year ending December 31, 2019 was USD 22.08 M, a -1.24% change year over year.
Key data
| Date | Goodwill | Total Assets | Current Liabilities | Total Non-Current Liabilities |
|---|
Market news
Loading...
Don’t Miss A Beat
Shanghai Stock Exchange: 688468.SS
| CEO | Ms. Yanling Huang |
| IPO Date | April 9, 2021 |
| Location | China |
| Headquarters | Incubator Building, 1st and 6th Floors |
| Employees | 731 |
| Sector | Healthcare |
| Industries | |
Description
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic testing reagents and instruments. Its products include LiCA series of diagnostic reagents based on photoinduced chemiluminescence method, and CC series diagnostic reagents and instruments based on enzymatic chemiluminescence method for primarily used in infectious diseases markers, tumor markers, thyroid hormones, reproduction detection of endocrine hormones, myocardial markers, and inflammation. The company was founded in 2007 and is based in Beijing, China.
Key trends
Past 5 years
StockViz Staff
February 2, 2025
Any question? Send us an email